Actively Recruiting
PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
Led by Poznan University of Medical Sciences · Updated on 2026-05-07
90
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate whether different types of regional anesthesia can improve pain control and functional recovery after total hip arthroplasty in adult patients undergoing elective hip replacement surgery. The main questions it aims to answer are: Does the PENG block reduce opioid use in the first 48 hours after surgery more effectively than the combined L-ESPB + S-ESPB technique? Which method provides better pain relief, preserves muscle strength, and supports earlier mobilization? Researchers will compare the Pericapsular Nerve Group (PENG) block with the combination of Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB + S-ESPB) to see which provides better pain control, fewer side effects, and faster recovery. Participants will: Be randomly assigned to receive one of the two types of ultrasound-guided regional anesthesia Undergo standard hip replacement surgery under spinal anesthesia Be monitored for pain scores, opioid use, time to first walking, muscle strength, satisfaction, and side effects over the first 48 hours after surgery.
CONDITIONS
Official Title
PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 years or older
- ASA physical status classification I to III
- Scheduled for elective unilateral total hip arthroplasty via posterior or lateral approach
- Provided informed consent to participate
You will not qualify if you...
- Allergy to ropivacaine or dexamethasone
- Chronic opioid use greater than 30 MME per day
- Coagulopathy or infection at injection site
- Body mass index over 40 kg/m²
- Pre-existing motor weakness or neuropathy in the affected limb
- Cognitive impairment preventing informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Poznan University of Medical Sciences
Poznan, Poland, 62-701
Actively Recruiting
Research Team
M
Malgorzata Reysner, M.D. Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here